Vor Biopharma Inc.
VOR
$0.59
-$0.044-6.94%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 91.93M | 62.81M | 85.94M | 107.48M | 137.18M |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 4.20M | 4.20M | 4.05M | 3.83M | 3.15M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 380.00K | 285.00K | 272.00K | 507.00K | 475.00K |
| Total Current Assets | 96.51M | 67.30M | 90.26M | 111.82M | 140.80M |
|
|
|||||
| Total Current Assets | 96.51M | 67.30M | 90.26M | 111.82M | 140.80M |
| Net Property, Plant & Equipment | 41.59M | 43.77M | 45.86M | 47.98M | 50.10M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 4.80M | 4.93M | 5.48M | 7.23M | 7.23M |
| Total Assets | 142.89M | 115.99M | 141.59M | 167.03M | 198.13M |
|
|
|||||
| Total Accounts Payable | 1.51M | 1.32M | 2.01M | 2.33M | 815.00K |
| Total Accrued Expenses | 12.89M | 8.87M | 7.68M | 6.93M | 10.93M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 4.22M | 4.16M | 4.11M | 3.96M | 3.83M |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | 18.61M | 14.35M | 13.80M | 13.21M | 15.57M |
|
|
|||||
| Total Current Liabilities | 18.61M | 14.35M | 13.80M | 13.21M | 15.57M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 27.62M | 28.69M | 29.71M | 30.78M | 31.83M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 46.23M | 43.04M | 43.51M | 44.00M | 47.40M |
|
|
|||||
| Common Stock & APIC | 553.64M | 499.17M | 496.87M | 494.01M | 490.88M |
| Retained Earnings | -456.99M | -426.28M | -398.72M | -370.88M | -340.08M |
| Treasury Stock & Other | 22.00K | 68.00K | -70.00K | -87.00K | -77.00K |
| Total Common Equity | 96.66M | 72.96M | 98.08M | 123.04M | 150.72M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 96.66M | 72.96M | 98.08M | 123.04M | 150.72M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 96.66M | 72.96M | 98.08M | 123.04M | 150.72M |
|
|
|||||
